Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensified Omeprazole to Prevent High Output Stoma
NCT06917963Recruiting
- Sponsor
- Medical University of Gdańsk
- Start
- Apr 2025
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of omeprazole in High output stoma (HOS) (2 arms), sponsored by Medical University of Gdańsk. Primary endpoint: Difference in mean ileostomy output. Started Apr 2025; status: recruiting.
02
Drugs
omeprazole
03
Conditions
High output stoma (HOS)
Beyond the preview
Go deeper on NCT06917963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06917963.